Showing results (301-310 of 320) with videos related to

Sort By:
Pageof 32
The Journal of Allergy and Clinical Immunology|October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trialBruce Zuraw, William R Lumry, Douglas T Johnston, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
Nature Communications|October 10, 2015
Genetic sharing and heritability of paediatric age of onset autoimmune diseasesYun R Li, Sihai D Zhao, Jin Li, et al.
Nucleic Acids Research|November 27, 2018
Expansion of the Human Phenotype Ontology (HPO) knowledge base and resourcesSebastian Köhler, Leigh Carmody, Nicole Vasilevsky, et al.
The Journal of Allergy and Clinical Immunology|October 5, 2016
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantationM Teresa de la Morena, David Leonard, Troy R Torgerson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 12, 2024
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary AngioedemaRemy S Petersen, Lauré M Fijen, Christian Apfelbacher, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2020
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutationsTiziana Lorenzini, Manfred Fliegauf, Nils Klammer, et al.
Nature Medicine|August 25, 2015
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseasesYun R Li, Jin Li, Sihai D Zhao, et al.
Contemporary Clinical Trials|December 14, 2020
A randomized, open-label, pragmatic study to assess reliever-triggered inhaled corticosteroid in African American/Black and Hispanic/Latinx adults with asthma: Design and methods of the PREPARE trialElliot Israel, Juan Carlos Cardet, Jennifer K Carroll, et al.
Pageof 32